
Loading, please wait...

Loading, please wait...

Recently published research by Sharma A et al. explores how neural states in Parkinson's underpin motor symptom severity. The team analyzed over 1,000 hours of chronic recordings using a Hidden Markov Model. Specifically, these findings support the development of adaptive deep brain stimulation by identifying specific biomarkers for bradykinesia and tremor.
Additionally, researchers identified four distinct neural states during the longitudinal analysis. Consequently, spectral signatures involving subthalamic nucleus (STN) gamma and delta/alpha oscillations predicted worsening bradykinesia. While STN beta activity did not predict bradykinesia, it significantly predicted tremor severity. Furthermore, high STN gamma activity consistently signaled the presence of dyskinesia.
Moreover, the longitudinal analysis demonstrated that these neural states remain stable over several months. Therefore, clinicians might use these specific oscillatory patterns to fine-tune stimulation parameters in real-time. This data-driven approach moves beyond simple beta-band monitoring. Instead, it offers a more comprehensive network-wide analysis of neural dynamics to improve patient outcomes.
Neural states refer to transient patterns of local and interregional oscillatory synchrony within brain circuits. In Parkinson's, these states help predict the severity of specific motor symptoms like tremor or bradykinesia.
By identifying stable neural biomarkers through chronic recordings, this research provides a blueprint for adaptive DBS. This allows for neurostimulation that adjusts automatically based on the patient's current neural state and symptom profile.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Sharma A et al. Dynamic neural states underpin motor symptom severity in Parkinson's disease: a longitudinal analysis of chronic cortico-subthalamic nucleus recordings. EBioMedicine. 2026 May 12. doi: undefined. PMID: 42119302.
Oehrn CR, et al. Neural biomarkers for closed-loop deep brain stimulation in Parkinson’s disease. Nature Communications. 2024.
Little S, Brown P. The Functional Role of Beta Oscillations in Parkinson's Disease. Movement Disorders. 2020.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers identify four neural states that predict motor symptom severity in Parkinson's, providing a blueprint for long-term adaptive neurostimulation....
5 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A randomized controlled trial demonstrates that an eight-week dual-task training intervention significantly improves static and dynamic postural control over standard balance exercises in individuals with chronic ankle instability, addressing critical neurocognitive deficits during athletic and daily activities.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today